Last week, the U.S. Food and Drug Administration (FDA) issued the draft guidance, “Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs,” regarding formal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback